Cingulate Inc. Delays Quarterly Report Filing

Cingulate Inc ( (CING) ) has released a notification of late filing.

Cingulate Inc., a company based in Kansas City, Kansas, has announced a delay in filing its Form 10-Q (Quarter Report) for the financial period ending June 30, 2025. The delay is primarily due to recent changes in the company’s management, which have necessitated additional time to review and prepare the financial statements and related disclosures. The company assures that the report will be filed within the five-day extension period allowed under Rule 12b-25. Cingulate Inc. does not anticipate any significant change in its financial results compared to the same period last year. The notification was signed by Jennifer L. Callahan, the Interim Chief Executive Officer and Chief Financial Officer, who emphasized the company’s commitment to ongoing compliance efforts.

The most recent analyst rating on (CING) stock is a Buy with a $8.00 price target. To see the full list of analyst forecasts on Cingulate Inc stock, see the CING Stock Forecast page.

Spark’s Take on CING Stock

According to Spark, TipRanks’ AI Analyst, CING is a Neutral.

Cingulate Inc.’s overall stock score is primarily impacted by its poor financial performance, with persistent losses and negative cash flows. However, recent corporate developments, such as securing a grant and progress towards FDA approval, provide a positive outlook. The technical analysis shows neutral momentum, but valuation remains a concern due to financial losses and lack of dividends.

To see Spark’s full report on CING stock, click here.

More about Cingulate Inc

Average Trading Volume: 166,953

Technical Sentiment Signal: Sell

Current Market Cap: $21.25M

For detailed information about CING stock, go to TipRanks’ Stock Analysis page.